Author [ Title] Type Year
Filters: Author is Mohankumar, Kumarasamypet M and Keyword is Gene Editing [Clear All Filters]
B
Rajendiran V, Devaraju N, Haddad M, Ravi NSam, Panigrahi L, Paul J, Gopalakrishnan C, Wyman S, Ariudainambi K, Mahalingam G, Periyasami Y, Prasad K, George A, Sukumaran D, Gopinathan S, Pai AAnand, Nakamura Y, Balasubramanian P, Ramalingam R, Thangavel S et al..
2024. Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expression.. Mol Ther. 32(3):663-677. DOI:10.1016/j.ymthe.2024.01.023.
C
Prasad K, George A, Ravi NSam, Mohankumar KM.
2021. CRISPR/Cas based gene editing: marking a new era in medical science.. Mol Biol Rep. 48(5):4879-4895. DOI:10.1007/s11033-021-06479-7.
G
Devaraju N, Rajendiran V, Ravi NSam, Mohankumar KM.
2022. Genome Engineering of Hematopoietic Stem Cells Using CRISPR/Cas9 System.. Methods Mol Biol. 2429:307-331. DOI:10.1007/978-1-0716-1979-7_20.
I
Ravi NSam, Wienert B, Wyman SK, Bell HWilliam, George A, Mahalingam G, Vu JT, Prasad K, Bandlamudi BPrasad, Devaraju N, Rajendiran V, Syedbasha N, Pai AAnand, Nakamura Y, Kurita R, Narayanasamy M, Balasubramanian P, Thangavel S, Marepally S, Velayudhan SR et al..
2022. Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin.. Elife. 11 DOI:10.7554/eLife.65421.
P
Ravi NSam, George A, Mohankumar KM.
2023. Protocol for arrayed gRNA screening by base editors in mammalian cell lines using lentiviral system.. STAR Protoc. 4(4):102668. DOI:10.1016/j.xpro.2023.102668.